Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | PDK2 | Q15119 | 17/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6293012 | 0.93 | PDK2 (0.43) | MGLLCA1CA2PDK2 | |
| SCHEMBL31367626 | 0.92 | PDK2 (0.50) | MGLLCA1CA2PDK2 | |
| SCHEMBL19383274 | 0.92 | PDK2 (0.50) | MGLLCA1CA2PDK2 | |
| SCHEMBL17470490 | 0.92 | PDK2 (0.50) | MGLLCA1CA2PDK2 | |
| SCHEMBL13599939 | 0.91 | MGLL (0.49) | MGLLCA1CA2PDK2 | |
| SCHEMBL26831143 | 0.90 | MGLL (0.50) | MGLLCA1CA2PDK2 | |
| SCHEMBL12551794 | 0.87 | MGLL (0.56) | MGLLCA1CA2PDK2 | |
| SCHEMBL30346522 | 0.86 | CA1 (0.44) | MGLLCA1CA2PDK2 | |
| SCHEMBL19193785 | 0.86 | CA1 (0.44) | MGLLCA1CA2PDK2 | |
| SCHEMBL29602907 | 0.86 | CA1 (0.44) | MGLLCA1CA2PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807630-B2 | Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-11-07 | — | — | US | disclosed |
| US-20200277272-A1 | COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2020-09-03 | — | — | US | disclosed |
| EP-3683212-A1 | COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENT ELEMENT | Hodogaya Chemical Co., Ltd. (JP) | 2020-07-22 | — | — | EP | disclosed |
| CN-111094264-A | Compound having pyrimidine ring structure and organic electroluminescent element | 保土谷化学工业株式会社 | 2020-05-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200277272-A1 | COMPOUND HAVING PYRIMIDINE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | SLC29A1, ADORA1, SLC29A2 | MGLL 4314/4885CA1 4514/4885CA2 4203/4885 |
| US-11807630-B2 | Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof | PIEZO1, OCIAD1, OR10J3 | MGLL 3712/4885CA1 570/4885CA2 860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.